Laura J. Zitella, MS, RN, ACNP-BC, AOCN, explains that later cytopenias should be monitored in patients undergoing CAR T-cell ...

The FDA has approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) for use in patients with high-risk ...

Integrative oncology is a patient-centered approach to cancer care that looks at the whole patient and combines their ...

Daniela Gehrke, BSN, RN, OCN, CIC, is the clinical manager of IC and safety for Texas Oncology, a part of The US Oncology Network.

Among lymphoma survivors experiencing chronic fatigue, a multidisciplinary intervention program has been found to have a ...

While at 3 months fewer patients in supervised physical activity arm reported visual analog scale loss of energy (45% vs 62%) ...

Opening discussions about priorities and learning about inclusive language are among the most impactful steps an advanced ...

Insurance navigation remains a complex but essential skill for oncology advanced practice providers (APPs). According to ...

La-Urshalar Brock, FNP-BC, CNM, describes tactics for managing dermatologic AEs in patients with breast cancer as part of a ...

Kevin Y. Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment ...

Imatinib (Gleevec) showed durable efficacy in advanced gastrointestinal stromal tumors (GIST), with complete response (CR) or complete resection yielding a twofold increase in median survival, ...